氯胺酮用于重症外科与创伤机械通气患者的主要镇痛镇静
该回顾性队列研究纳入2015至2019年明尼苏达州某学术医疗中心外科ICU中需要机械通气、符合三种氯胺酮主要镇痛镇静定义之一的164例患者。88%的患者从未接受合并阿片输注(定义1),12%符合定义2和3。氯胺酮中位剂量0.18 mg/kg/hr(0.1-0.3),中位持续30小时(15.1-51.8);输注期间疼痛评分达标中位百分比62%(33-96%),Richmond躁动镇静量表评分达标64%(37-91%),47%的患者Confusion Assessment Method-ICU阳性,14%记录到幻觉,11%的患者氯胺酮失败。作者认为氯胺酮可能是插管外科ICU患者有效的首要镇痛镇静选择,但需要前瞻性随机研究评估该策略。
要点
- 164例外科/创伤ICU机械通气患者中,88%从未接受合并阿片输注,符合氯胺酮主要镇痛镇静定义1。
- 氯胺酮中位输注剂量0.18 mg/kg/hr(0.1-0.3),中位持续30小时(15.1-51.8)。
- 输注期间疼痛评分达标中位百分比62%(33-96%),Richmond躁动镇静量表评分达标64%(37-91%)。
- 47%的患者在氯胺酮输注期间Confusion Assessment Method-ICU阳性,14%记录到幻觉。
- 11%的患者发生氯胺酮失败(因无效或毒性),作者认为需前瞻性随机研究评估该策略。
适用人群与场景
- 2015至2019年入住外科ICU、需要机械通气、符合三种氯胺酮主要镇痛镇静定义之一的外科/创伤患者;68%为外科入院,平均急性生理与慢性健康评分III为90(±30)。
诊断标准与关键阈值
- 氯胺酮主要镇痛镇静定义1:无合并阿片输注。
- 定义2:氯胺酮单药治疗大于等于6小时,随后接受阿片输注。
- 定义3:氯胺酮与阿片同时启动或在阿片启动后4小时内启动,且阿片总持续时间小于4小时。
处置流程与药物剂量
- 氯胺酮中位输注剂量0.18 mg/kg/hr(0.1-0.3),中位输注持续时间30小时(15.1-51.8)。
- 合并丙泊酚输注者占49%,合并右美托咪定输注者占29%。
红旗征与不能漏的情况
- 氯胺酮输注期间14%的患者记录到幻觉。
- 11%的患者发生氯胺酮失败(因无效或毒性)。
研究设计与关键结果
- 回顾性队列研究,纳入164例外科ICU机械通气患者;88%从未接受合并阿片输注(定义1),12%符合定义2和3。
- 中位机械通气时间2.5天(1.1-4.5),ICU住院时间4.9天(3-8)。
- 氯胺酮输注期间疼痛评分达标中位百分比62%(33-96%),Richmond躁动镇静量表评分达标64%(37-91%),47%的患者Confusion Assessment Method-ICU阳性。
- 幻觉发生率14%,氯胺酮失败率11%。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为氯胺酮可能是插管外科ICU患者有效的首要镇痛镇静选择,但需要前瞻性随机研究评估该策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Evaluate effectiveness and safety outcomes associated with the use of ketamine for primary analgosedation in the surgical/trauma ICU setting.
DESIGN: Retrospective cohort study.
SETTING: Academic medical center in Minnesota.
PATIENTS: Patients admitted to the surgical ICU between 2015 and 2019 requiring mechanical ventilation and meeting one of three definitions for ketamine primary analgosedation were included: 1) no concomitant opioid infusion, 2) ketamine monotherapy for greater than or equal to 6 hours with subsequent opioid infusion, or 3) ketamine initiated concomitantly or within 4 hours of opioid and total opioid duration less than 4 hours.
INTERVENTIONS: None.
MEASUREMENTS: Use of ketamine, analgesics, and sedatives were evaluated. Pain, sedation, and delirium assessments immediately before and during ketamine infusion were collected and compared with reported goals. Concomitant analgesics, sedatives, and psychotropics were recorded. Reported failures due to ineffectiveness and toxicity were collected.
MAIN RESULTS: Of 164 included patients, 88% never received a concomitant opioid infusion (primary analgosedation definition 1), 12% met alternative criteria for primary analgosedation (definitions 2 and 3). A majority, 68%, were surgical admissions and mean Acute Physiology and Chronic Health Evaluation III score was 90 (± 30). Median mechanical ventilation duration was 2.5 days (1.1-4.5) and ICU length of stay of 4.9 days (3-8). The median ketamine infusion dose and duration were 0.18 mg/kg/hr (0.1-0.3) and 30 hours (15.1-51.8). Concomitant infusions of propofol and dexmedetomidine were administered in 49% and 29% of patients, respectively. During ketamine infusion, the median percent of total pain scores at goal was 62% (33-96%), while 64% (37-91%) of Richmond Agitation Sedation Scale scores were at goal, and 47% of patients were Confusion Assessment Method-ICU positive during the ketamine infusion. Hallucinations were documented in 14% of patients and ketamine failure occurred in 11% of patients.
CONCLUSIONS: Ketamine may be an effective primary analgosedation option in intubated surgical ICU patients, but prospective randomized studies are needed to evaluate this strategy.
参考来源
- Peters BJ, Kooda KJ, Brown CS, et al. Ketamine for Primary Analgosedation in Critically Ill Surgery and Trauma Patients Requiring Mechanical Ventilation. Crit Care Explor. 2024. PMID: 38283259. doi:10.1097/CCE.0000000000001041
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。